Partner: J. Brągoszewski

Military Institute of Medicine (PL)

Recent publications
1.Kowalewski P.K., Olszewski R., Walędziak M.S., Janik M.R., Kwiatkowski A., Gałązka-Świderek N., Cichoń K., Brągoszewski J., Paśnik K., Long-term outcomes of laparoscopic sleeve gastrectomy-a single-center, retrospective study, Obesity Surgery, ISSN: 0960-8923, DOI: 10.1007/s11695-017-2795-2, Vol.28, No.1, pp.130-134, 2018
Abstract:

Introduction Sleeve gastrectomy (LSG) is one of the most popular bariatric procedures. We present our long-term results regarding weight loss, comorbidities, and gastric reflux disease. Material and Methods We identified patients who underwent LSG in our institution between 2006 and 2009. We revised the data, and the patients with outdated contact details were tracked with the national health insurance database and social media (facebook). Each of the identified patients was asked to complete an online or telephone survey covering, among others, their weight and comorbidities. On that basis, we calculated the percent total weight loss (%TWL) and percent excess weight loss (%EWL), along with changes in body mass index (ΔBMI). Satisfactory weight loss was set at >50% EWL (for BMI = 25 kg/m2). We evaluated type 2 diabetes (T2DM) and arterial hypertension (AHT) based on the pharmacological therapy. GERD presence was evaluated by the typical symptoms and/or proton pump inhibitor (PPI) therapy. Results One hundred twenty-seven patients underwent LSG between 2006 and 2009. One hundred twenty patients were qualified for this study. Follow-up data was available for 100 participants (47 female, 53 male). Median follow-up period reached 8.0 years (from 7.1 to 10.7). Median BMI upon qualification for LSG was 51.6 kg/m2. Sixteen percent of patients required revisional surgery over the years (RS group), mainly because of insufficient weight loss (14 Roux-Y gastric bypass—LRYGB; one mini gastric bypass, one gastric banding). For the LSG (LSG group n = 84), the mean %EWL was 51.1% (±22.3), median %TWL was 23.5% (IQR 17.7–33.3%), and median ΔBMI was 12.1 kg/m2 (IQR 8.2–17.2). Fifty percent (n = 42) of patients achieved the satisfactory %EWL of 50%. For RS group, the mean %EWL was 57.8%(±18.2%) and median %TWL reached 33% (IQR 27.7–37.9%). Sixty-two percent (n = 10) achieved the satisfactory weight loss. Fifty-nine percent of patients reported improvement in AHT therapy, 58% in T2DM. After LSG, 60% (n = 60) of patients reported recurring GERD symptoms and 44% were treated with proton pomp inhibitors (PPI). In 93% of these cases, GERD has developed de novo. Conclusions Isolated LSG provides fairly good effects in a long-term follow-up with mean %EWL at 51.1%. Sixteen percent of patients require additional surgery due to insufficient weight loss. More than half of the subjects observe improvement in AHT and T2DM. Over half of the patients complain of GERD symptoms, which in most of the cases is a de novo complaint.

Keywords:

bariatric surgery, sleeve, long-termfollow-up, comorbidities, GERD

Affiliations:
Kowalewski P.K.-Military Institute of Medicine (PL)
Olszewski R.-IPPT PAN
Walędziak M.S.-Military Institute of Medicine (PL)
Janik M.R.-Military Institute of Medicine (PL)
Kwiatkowski A.-Military Institute of Medicine (PL)
Gałązka-Świderek N.-Regional Hospital (PL)
Cichoń K.-Regional Hospital (PL)
Brągoszewski J.-Military Institute of Medicine (PL)
Paśnik K.-Military Institute of Medicine (PL)